DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: In a set of muscular dystrophies known as the dystroglycanopathies, hypoglycosylation of the DGC component α-dystroglycan results in reduced binding to basal lamina components, a loss in structural stability, and repeated cycles of muscle fiber degeneration and regeneration.